公开(公告)号：US20120156829A1

公开(公告)日：2012-06-21

申请号：US13393218

申请日：2010-04-30

Applicant: Zhikuan Chen ,  Jun Li ,  Beng Ong ,  Samarendra P. Singh ,  Hoi Kai Ivy Wong ,  Kok Haw Ong

Inventor： Zhikuan Chen ,  Jun Li ,  Beng Ong ,  Samarendra P. Singh ,  Hoi Kai Ivy Wong ,  Kok Haw Ong

IPC: H01L51/40 ,  C08G75/32 ,  C08G75/06

CPC classification number: H01L51/0036 ,  B82Y10/00 ,  C07D285/14 ,  C07D333/10 ,  C07D333/28 ,  C07D417/14 ,  C07D495/14 ,  C08G61/126 ,  C08G2261/3223 ,  C08G2261/3246 ,  C08G2261/364 ,  H01L51/0047 ,  H01L51/0525 ,  H01L51/0545 ,  H01L51/4253 ,  Y02E10/549

Abstract: A polymer comprises a polymeric chain represented by formula (I) or (II). In formula (I), a, b, c, d, and n are integers, a from 0 to 3, b from 1 to 5, c from 1 to 3, d from 1 to 5, and n from 2 to 5000; R1 and R2 are side chains; R3 and R4 are each independently II or a side chain; and when a is 0, R3 and R4 are side chains. In formula (II), a, b, c, d, e, and n are integers, a from 1 to 3, b and c being independently 0 or 1, d and e being independently 1 or 2, and n from 2 to 5000; R1 and R2 are side chains except —COOalkyl; and X1, X2 and X3 are independently O, S, or Se. Semiconductors and devices comprising the polymer are also provided.

Abstract translation: 聚合物包含由式（I）或（II）表示的聚合物链。 在式（I）中，a，b，c，d和n为整数，a为0至3，b为1至5，c为1至3，d为1至5，n为2至5000; R1和R2是侧链; R3和R4各自独立地为II或侧链; 当a为0时，R 3和R 4为侧链。 在式（II）中，a，b，c，d，e和n为整数，a为1至3，b和c独立地为0或1，d和e独立地为1或2，n为2至 5000; R1和R2是除-COO烷基以外的侧链; X 1，X 2和X 3独立地为O，S或Se。 还提供了包含聚合物的半导体和器件。

公开(公告)号：US20120130694A1

公开(公告)日：2012-05-24

申请号：US12953080

申请日：2010-11-23

Applicant: Deepak Srivastava ,  Sang Yang ,  Jun Li

Inventor： Deepak Srivastava ,  Sang Yang ,  Jun Li

IPC: G06G7/48

CPC classification number: G06F19/00 ,  H01M10/00 ,  H01M10/0525

Abstract: Methods and computer programs to quantify defects in an experimentally synthesized material for use in a battery are provided. A method includes an operation for obtaining spectra of the experimentally synthesized material. Further, defected structures of a crystalline structure are created via simulation, and spectra of the defected structures are obtained via simulation. In another method operation, the spectra of the experimentally synthesized material is compared to the spectra of the defected structures obtained via simulation, and if the spectra of the experimentally synthesized material is substantially equal to the spectra of the defected structures obtained via simulation then the defects in the experimentally synthesized material are quantified according to the defects in the defected structures.

Abstract translation: 提供了用于量化用于电池的实验合成材料中的缺陷的方法和计算机程序。 一种方法包括获得实验合成材料的光谱的操作。 此外，通过模拟产生晶体结构的缺陷结构，并且通过模拟获得缺陷结构的光谱。 在另一种方法操作中，将实验合成材料的光谱与通过模拟获得的缺陷结构的光谱进行比较，并且如果实验合成材料的光谱基本上等于通过模拟获得的缺陷结构的光谱，则缺陷 在实验合成材料中根据缺陷结构的缺陷量化。

公开(公告)号：US20120130690A1

公开(公告)日：2012-05-24

申请号：US12953048

申请日：2010-11-23

Applicant: Deepak SRIVASTAVA ,  Jun Li ,  Sang Yang

Inventor： Deepak SRIVASTAVA ,  Jun Li ,  Sang Yang

IPC: G06F17/10 ,  G06F17/50

CPC classification number: H01M10/0525 ,  G06F17/5009 ,  G06F2217/16 ,  G16C10/00 ,  G16C20/30 ,  Y02T10/7011

Abstract: Methods, systems, and computer programs for selecting electrode materials for a lithium battery are presented. In one embodiment, a method includes an operation for developing models for structural and energy analysis of battery stability, safety, cycling and performance, where the models are developed based on a selection of elements and compositions for the electrode materials. Properties of at least one cell performance parameter are estimated, and a cell discharge rate behavior is calculated. Another operation in the method is provided for selecting an electrode material composition based on the estimated properties and the cell discharge rate behavior. The method operations are performed by a computer system that includes a processor.

Abstract translation: 提出了用于选择锂电池的电极材料的方法，系统和计算机程序。 在一个实施例中，一种方法包括用于开发用于电池稳定性，安全性，循环和性能的结构和能量分析的模型的操作，其中基于用于电极材料的元件和组合物的选择来开发模型。 估计至少一个细胞性能参数的性质，并计算细胞放电速率行为。 提供了该方法中的另一操作，用于基于估计的性质和电池放电速率行为来选择电极材料组成。 方法操作由包括处理器的计算机系统执行。

公开(公告)号：US20120127969A1

公开(公告)日：2012-05-24

申请号：US13386923

申请日：2010-07-13

Applicant: Yong He ,  Xiao-jun Ma ,  Jun Li

Inventor： Yong He ,  Xiao-jun Ma ,  Jun Li

IPC: H04W72/04

CPC classification number: H04W74/085

Abstract: A method and apparatus are described including determining if a successful unicast transmission has occurred, adjusting a contention window to a minimum value and adjusting a time slot back-off counter to one-half of the value of the contention window plus one responsive to the determination and adjusting the contention window using one of a plurality of adjustment schemes and selecting said time slot back-off counter from an interval between zero and the contention window.

Abstract translation: 描述了一种方法和装置，包括确定是否已经发生了成功的单播传输，将竞争窗口调整到最小值并且将响应于该确定的竞争窗口值的一半调整到时隙退避计数器的一半 以及使用多个调整方案中的一个调整所述争用窗口，并且从所述争用窗口之间的间隔中选择所述时隙退避计数器。

公开(公告)号：US08149643B2

公开(公告)日：2012-04-03

申请号：US12288984

申请日：2008-10-23

Applicant: Joseph Tzou ,  Thinh Tran ,  Jun Li

Inventor： Joseph Tzou ,  Thinh Tran ,  Jun Li

IPC: G11C8/00

CPC classification number: G11C8/18 ,  G11C8/12

Abstract: A memory device and method may include separating alternating read and write accesses to different banks of a memory device.

Abstract translation: 存储器件和方法可以包括将交替的读和写访问分离到存储器件的不同组。

公开(公告)号：US08148396B2

公开(公告)日：2012-04-03

申请号：US12424674

申请日：2009-04-16

Applicant: James J. Li ,  Lawrence G. Hamann ,  Haixia Wang ,  Zheming Ruan ,  Christopher B. Cooper ,  Jun Li ,  Jeffrey A. Robl

Inventor： James J. Li ,  Lawrence G. Hamann ,  Haixia Wang ,  Zheming Ruan ,  Christopher B. Cooper ,  Jun Li ,  Jeffrey A. Robl

IPC: A01N43/42 ,  A61K31/44 ,  C07D513/02

CPC classification number: C07D471/04

Abstract: Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof wherein W, L, R3, R3a, R3b and R4 are defined herein.

Abstract translation: 提供了新的化合物，其为11-β-羟基类固醇脱氢酶I型抑制剂。 11-β-羟基类固醇脱氢酶I型抑制剂可用于治疗，预防或减缓需要11-β-羟基类固醇脱氢酶I型抑制剂治疗的疾病进展。 这些新化合物具有以下结构：其中W，L，R 3，R 3a，R 3b和R 4在本文中定义的立体异构体或前药或其药学上可接受的盐。

公开(公告)号：US08143425B2

公开(公告)日：2012-03-27

申请号：US11247491

申请日：2005-10-11

Applicant: William R. Ewing ,  Jun Li ,  Richard B. Sulsky ,  Andres S. Hernandez

Inventor： William R. Ewing ,  Jun Li ,  Richard B. Sulsky ,  Andres S. Hernandez

IPC: A61K31/415 ,  C07D231/12

CPC classification number: C07D231/12 ,  C07D231/20 ,  C07D249/08 ,  C07D261/04 ,  C07D261/08 ,  C07D271/10 ,  C07D271/107 ,  C07D403/12 ,  C07D413/12

Abstract: Novel heterocyclic aromatic compounds are provided that are useful in stimulating endogenous production or release of growth hormone, said compounds having the general structure of formula I wherein R1, R1a, R6, Xa, Xb and Y are as described herein. The compounds provided herein are useful in treating obesity, osteoporosis (improving bone density) and in improving muscle mass and muscle strength.

Abstract translation: 提供了可用于刺激生长激素的内源性产生或释放的新型杂环芳族化合物，所述化合物具有通式I的通式结构，其中R1，R1a，R6，Xa，Xb和Y如本文所述。 本文提供的化合物可用于治疗肥胖症，骨质疏松症（改善骨密度）和改善肌肉质量和肌肉力量。

公开(公告)号：US08110703B2

公开(公告)日：2012-02-07

申请号：US12994862

申请日：2009-05-31

Applicant: Feihu Chen ,  Jingbo Shi ,  Yuan Wang ,  Jun Li ,  Juan Shen ,  Jingjing Ruan ,  Fanrong Wu

Inventor： Feihu Chen ,  Jingbo Shi ,  Yuan Wang ,  Jun Li ,  Juan Shen ,  Jingjing Ruan ,  Fanrong Wu

IPC: C07C69/74 ,  C07C321/00 ,  C07C229/00 ,  C07C233/00 ,  C07C327/00 ,  A01N37/10 ,  A01N37/18 ,  A61K31/165

CPC classification number: C07C69/734 ,  C07C219/34 ,  C07C235/38 ,  C07C255/55 ,  C07C255/60 ,  C07C403/20 ,  C07C2601/16

Abstract: The invention relates to a retinoid derivative and pharmaceutical composition and use thereof. The compound of the invention is capable of preventing or treating hematological tumors, such as acute leukemia, chronic leukemia, multiple myeloma and lymphoma, solid tumors, such as liver cancer, rectal cancer, mammary cancer and esophagus cancer, and skin disorders, such as psoriasis and acne.

Abstract translation: 本发明涉及类视黄醇衍生物及其药物组合物及其用途。 本发明的化合物能够预防或治疗诸如急性白血病，慢性白血病，多发性骨髓瘤和淋巴瘤，实体瘤如肝癌，直肠癌，乳腺癌和食道癌等血液肿瘤和皮肤病，例如 牛皮癣和痤疮。

公开(公告)号：US20120030120A1

公开(公告)日：2012-02-02

申请号：US12847763

申请日：2010-07-30

Applicant: Nelson Souto Rosa ,  Fernando Antonio Aires Lins ,  Robson Wagner Albuquerque da Medeiros ,  Paulo Romero Martins Maciel ,  Julio Cesar Damasceno ,  Bruno Leonardo Barros Silva ,  Andre Ricardo Da Silva Souza ,  Bryan Stephenson ,  Hamid Reza Motahari-Nezhad ,  Jun Li ,  Caio Northfleet

Inventor： Nelson Souto Rosa ,  Fernando Antonio Aires Lins ,  Robson Wagner Albuquerque da Medeiros ,  Paulo Romero Martins Maciel ,  Julio Cesar Damasceno ,  Bruno Leonardo Barros Silva ,  Andre Ricardo Da Silva Souza ,  Bryan Stephenson ,  Hamid Reza Motahari-Nezhad ,  Jun Li ,  Caio Northfleet

IPC: G06F21/00

CPC classification number: G06Q10/067

Abstract: A functional model of a business process which is annotated with security requirements is provided. Platform-specific executable code and at least one configuration file for a given security enforcement component to enforce the security requirements of the model are then generated automatically.

Abstract translation: 提供了具有安全要求注释的业务流程的功能模型。 然后自动生成特定于平台的可执行代码以及至少一个用于给定安全执行组件来强制执行模型安全性要求的配置文件。

公开(公告)号：US20110288051A1

公开(公告)日：2011-11-24

申请号：US13197273

申请日：2011-08-03

Applicant: Jun Li ,  Jeffrey A. Robl ,  James J. Li ,  Lawrence J. Kennedy ,  Haixia Wang ,  Jie Jack Li ,  Chenkou Wei ,  Michael Galella

Inventor： Jun Li ,  Jeffrey A. Robl ,  James J. Li ,  Lawrence J. Kennedy ,  Haixia Wang ,  Jie Jack Li ,  Chenkou Wei ,  Michael Galella

IPC: A61K31/695 ,  C07F7/10 ,  A61K31/437 ,  A61P3/00 ,  A61P5/08 ,  A61P19/02 ,  A61P27/06 ,  A61P19/08 ,  A61P3/10 ,  A61P3/04 ,  A61P3/06 ,  A61P25/00 ,  C07D471/02 ,  A61P9/12

CPC classification number: C07D471/04

Abstract: Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R3, R3a, and R3b are defined herein.

Abstract translation: 提供了新的化合物，其为11-β-羟基类固醇脱氢酶I型抑制剂。 11-β-羟基类固醇脱氢酶I型抑制剂可用于治疗，预防或减缓需要11-β-羟基类固醇脱氢酶I型抑制剂治疗的疾病进展。 这些新颖的式I化合物或其立体异构体或其药学上可接受的盐，其中G，Q，X，Y，R 3，R 3a和R 3b在本文中定义。